PREVENAR

This brand name is authorized in Estonia, Ireland, Lithuania, South Africa.

Active ingredients

The drug PREVENAR contains a combination of these active pharmaceutical ingredients (APIs):

1	Pneumococcus antigen, serotype 4 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
2	Pneumococcus antigen, serotype 6B UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
3	Pneumococcus antigen, serotype 9V UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
4	Pneumococcus antigen, serotype 14 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
5	Pneumococcus antigen, serotype 18C UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
6	Pneumococcus antigen, serotype 19F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen
7	Pneumococcus antigen, serotype 23F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE
	Read more about Pneumococcus, purified polysaccharides antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07AL02	Pneumococcus, purified polysaccharides antigen conjugated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AL Pneumococcal vaccines
Discover more medicines within J07AL02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1012767, 1063202, 1063235, 1063246, 1368187
LT	Valstybinė vaistų kontrolės tarnyba	1007899, 1007900, 1008542, 1008543, 1030399, 1030400, 1030401, 1033099
ZA	Health Products Regulatory Authority	35/30.1/0239